$2.5 Million Awarded to Plaintiff Who Suffered Gynecomastia

risperdal_lawsuit_risperdal_lawsuit_settlements_risperdal_side_effects_risperdal_gynecomastia_risperdal_breast_developmentAt 7 years-old, a boy with autism started taking Risperdal; four years in, the boy experienced dramatic physical changes. He started to grow breasts.

What is Risperdal? And what does it have to do with male breast growth?

Risperdal is an anti-psychotic drug manufactured by Janssen, a unit of Johnson & Johnson. The drug is known to cause male breast growth.

Risperdal activates a hormone called prolactin, which is responsible for breast growth and lactation in women.

A Danger to Children

Children’s bodies are particularly sensitive to prolactin. Janssen knew about the risk of Risperdal male breast growth in children, but did not share this with the U.S. Food and Drug Administration (FDA).

Johnson & Johnson Punished

The family of the autistic boy who used Risperdal filed a lawsuit against Janssen. Their Risperdal lawsuit claimed that Janssen covered up the risk of male breast growth―also called gynecomastia―in children.

At the trial held in a Philadelphia court, the jury agreed with the family’s claim, and awarded them with $2.5 million in compensation.

Our Role Is to Help You

Our team of attorneys is committed to helping anyone who has been injured by defective drugs. Carey Danis & Lowe helps countless families impacted by Risperdal and male breast growth. We are available to guide you through your legal options and compensation eligibility during a free case evaluation.

We Want to Hear from You

Contact Carey Danis & Lowe today. Call us at 800.721.2519, or submit a confidential personal injury claim form.

References: Pharmaceutical litigation, Risperdal
Tags: , ,